secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2026-11-09T21:01:27+00:00
Accession:  0001628280-26-072114
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Myriad grants one-time retention options to CFO, COO and CSO; full vest on third anniversary
--------------------------------------------------------------------------------

- Compensation Committee approved Nov 6, 2026 awards: CFO Benjamin R. Wheeler 121,379 options, COO Mark S. Verratti 146,933, CSO Dale Muzzey 92,632.
- Exercise price equals Myriad's closing stock price on the grant date; options vest and become exercisable in full on the third anniversary, subject to continued service.
- Options have a 10-year term; vested portions generally stay exercisable three months after termination other than death, disability or cause, and terminate immediately for cause.
- Company said the awards are meant to retain leadership continuity as it executes initiatives to improve operational efficiencies and financial performance.
- Awards remain subject to each executive's existing Severance and Change in Control Agreement; grants were made under the 2026 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000162828026072114/0001628280-26-072114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000162828026072114/mygn-20261106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-072114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer